Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.

@article{Megahed2001TreatmentOC,
  title={Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.},
  author={M. E. Megahed and Sherko von Schmiedeberg and Julian Becker and Thomas Ruzicka},
  journal={Journal of the American Academy of Dermatology},
  year={2001},
  volume={45 2},
  pages={256-9}
}
BACKGROUND Cicatricial pemphigoid (CP) is a rare autoimmune bullous disease that affects the skin and mucous membranes. It commonly ends by serious complications such as blindness, stenosis, and stricture formation and is difficult to treat. Mycophenolate mofetil has been reported to be effective in the treatment of pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid either as monotherapy or as a steroid-sparing agent. OBJECTIVE Our purpose was to evaluate the effectiveness of… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Similar Papers

Loading similar papers…